Observational studyJournal of neurology2026

Subcutaneous natalizumab administration in relapsing-remitting multiple sclerosis: results of EASIER 2 study.

Massimo Filippi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.